Therapeutics
-
Financial
U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program
FREDERICK, Md., March 1, 2023 /PRNewswire/ — Today, Theradaptive, a leading biotechnology company specializing in therapeutic delivery platforms, announces a Technology & Therapeutic Development…
Read More » -
Spine
HippoFi’s Regenerative Therapeutics Division Launches PURbridge™ for Spine Surgery
PURbridge™, an advanced synthetic and new form of bioactive glass, is positioned to significantly increase the Company’s revenue throughout 2023…
Read More » -
Financial
THE OLD MUTUAL GLOBAL INVESTORS UK LTD. INVESTS $901,000 IN ANIKA THERAPEUTICS INC. (ANIK)
February 2, 2017 – Jamie Williams Old Mutual Global Investors UK Ltd. purchased a new position in Anika Therapeutics Inc. (NASDAQ:ANIK)…
Read More » -
Biologics
InVivo Therapeutics Announces Sixth Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold™
CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that the patient enrolled in December in the INSPIRE study of…
Read More » -
Biologics
InVivo Therapeutics Announces INSPIRE’S 29th Clinical Site: Rhode Island Hospital
January 10, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Rhode Island Hospital in Providence, RI has been…
Read More » -
Financial
Bone Therapeutics Granted EUR 2.3 Million in Non-Dilutive Funding by the Walloon Region
January 06, 2017 GOSSELIES, Belgium–(BUSINESS WIRE)–Regulatory News: BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy…
Read More » -
Biologics
InVivo Therapeutics Responds to PixarBio Announcement
January 03, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today issued a response to a PixarBio Corporation press release dated…
Read More » -
Hospitals
Intrinsic Therapeutics announces the Filing of PMA Application for its Barricaid® Anular Closure Device for Lumbar Discectomy Patients.
BOSTON, Dec. 21, 2016 /PRNewswire/ — Intrinsic Therapeutics, Inc. announced today that the filing of its Pre-Market Approval (PMA) application with the Food…
Read More » -
Biologics
InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study
December 20, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient with a T8-9 fracture dislocation…
Read More » -
Biologics
Centrexion Therapeutics Announces Highly Statistically Significant Topline Results from Phase 2b Study of CNTX-4975 in Patients with Knee Osteoarthritis Pain
Boston – December 13, 2016 – Centrexion Therapeutics, a company focused on advancing the treatment of chronic pain with one of the largest…
Read More » -
Biologics
InVivo Therapeutics Appoints Melanie Morel-Ferris, C.P.A. as Interim CFO, Replacing Steven McAllister in Role
December 08, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the resignation of Steven McAllister from the position…
Read More » -
Financial
Flexion Therapeutics Announces Pricing of Public Offering of Common Stock
BURLINGTON, Mass., Nov. 16, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (FLXN) today announced the pricing of an underwritten public…
Read More » -
Financial
Osiris Therapeutics, Inc. Reports Preliminary 2014 and 2015 Revenue and Anticipated 2016 Revenue
COLUMBIA, Md., Nov. 07, 2016 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading regenerative medicine company focused on developing…
Read More » -
Financial
Flexion Therapeutics Reports Third Quarter 2016 Financial Results
BURLINGTON, Mass., Nov. 07, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced financial results for the third quarter…
Read More » -
Financial
InVivo Therapeutics Reports 2016 Third Quarter Financial Results and Business Update
November 04, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the quarter ended September 30,…
Read More »